Pre-order Enquiry
Request Free Sample
Global Influenza Drugs and Vaccines Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
SKU ID : GIR-21184626 | Publishing Date : 02-Jul-2022 | No. of pages : 111
Detailed TOC of Global Influenza Drugs and Vaccines Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
1 Market Overview1.1 Influenza Drugs and Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Influenza Drugs and Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Influenza Drugs
1.2.3 Influenza Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Influenza Drugs and Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Influenza Drugs and Vaccines Market Size & Forecast
1.4.1 Global Influenza Drugs and Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Influenza Drugs and Vaccines Sales in Volume (2017-2028)
1.4.3 Global Influenza Drugs and Vaccines Price (2017-2028)
1.5 Global Influenza Drugs and Vaccines Production Capacity Analysis
1.5.1 Global Influenza Drugs and Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Influenza Drugs and Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Influenza Drugs and Vaccines Market Drivers
1.6.2 Influenza Drugs and Vaccines Market Restraints
1.6.3 Influenza Drugs and Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Bristol Myers Squibb
2.1.1 Bristol Myers Squibb Details
2.1.2 Bristol Myers Squibb Major Business
2.1.3 Bristol Myers Squibb Influenza Drugs and Vaccines Product and Services
2.1.4 Bristol Myers Squibb Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Influenza Drugs and Vaccines Product and Services
2.2.4 AstraZeneca Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly Influenza Drugs and Vaccines Product and Services
2.3.4 Eli Lilly Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Influenza Drugs and Vaccines Product and Services
2.4.4 Roche Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Influenza Drugs and Vaccines Product and Services
2.5.4 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Influenza Drugs and Vaccines Product and Services
2.6.4 Novartis Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Influenza Drugs and Vaccines Product and Services
2.7.4 Pfizer Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sanofi Pasteur
2.8.1 Sanofi Pasteur Details
2.8.2 Sanofi Pasteur Major Business
2.8.3 Sanofi Pasteur Influenza Drugs and Vaccines Product and Services
2.8.4 Sanofi Pasteur Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business
2.9.3 Bayer Influenza Drugs and Vaccines Product and Services
2.9.4 Bayer Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Celgene
2.10.1 Celgene Details
2.10.2 Celgene Major Business
2.10.3 Celgene Influenza Drugs and Vaccines Product and Services
2.10.4 Celgene Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Seqirus
2.11.1 Seqirus Details
2.11.2 Seqirus Major Business
2.11.3 Seqirus Influenza Drugs and Vaccines Product and Services
2.11.4 Seqirus Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Protein Sciences Corporation
2.12.1 Protein Sciences Corporation Details
2.12.2 Protein Sciences Corporation Major Business
2.12.3 Protein Sciences Corporation Influenza Drugs and Vaccines Product and Services
2.12.4 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Serum Institute of India
2.13.1 Serum Institute of India Details
2.13.2 Serum Institute of India Major Business
2.13.3 Serum Institute of India Influenza Drugs and Vaccines Product and Services
2.13.4 Serum Institute of India Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Emergent Biosolutions
2.14.1 Emergent Biosolutions Details
2.14.2 Emergent Biosolutions Major Business
2.14.3 Emergent Biosolutions Influenza Drugs and Vaccines Product and Services
2.14.4 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 BioCryst Pharmaceuticals
2.15.1 BioCryst Pharmaceuticals Details
2.15.2 BioCryst Pharmaceuticals Major Business
2.15.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product and Services
2.15.4 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Alvogen
2.16.1 Alvogen Details
2.16.2 Alvogen Major Business
2.16.3 Alvogen Influenza Drugs and Vaccines Product and Services
2.16.4 Alvogen Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Influenza Drugs and Vaccines Breakdown Data by Manufacturer
3.1 Global Influenza Drugs and Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Influenza Drugs and Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Influenza Drugs and Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Influenza Drugs and Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Influenza Drugs and Vaccines Manufacturer Market Share in 2021
3.5 Global Influenza Drugs and Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Influenza Drugs and Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Influenza Drugs and Vaccines Market Size by Region
4.1.1 Global Influenza Drugs and Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Influenza Drugs and Vaccines Revenue by Region (2017-2028)
4.2 North America Influenza Drugs and Vaccines Revenue (2017-2028)
4.3 Europe Influenza Drugs and Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Influenza Drugs and Vaccines Revenue (2017-2028)
4.5 South America Influenza Drugs and Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Influenza Drugs and Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Influenza Drugs and Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Influenza Drugs and Vaccines Revenue by Type (2017-2028)
5.3 Global Influenza Drugs and Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Influenza Drugs and Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Influenza Drugs and Vaccines Revenue by Application (2017-2028)
6.3 Global Influenza Drugs and Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Influenza Drugs and Vaccines Sales by Type (2017-2028)
7.2 North America Influenza Drugs and Vaccines Sales by Application (2017-2028)
7.3 North America Influenza Drugs and Vaccines Market Size by Country
7.3.1 North America Influenza Drugs and Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Influenza Drugs and Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Influenza Drugs and Vaccines Sales by Type (2017-2028)
8.2 Europe Influenza Drugs and Vaccines Sales by Application (2017-2028)
8.3 Europe Influenza Drugs and Vaccines Market Size by Country
8.3.1 Europe Influenza Drugs and Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Influenza Drugs and Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Influenza Drugs and Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Influenza Drugs and Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Influenza Drugs and Vaccines Market Size by Region
9.3.1 Asia-Pacific Influenza Drugs and Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Influenza Drugs and Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Influenza Drugs and Vaccines Sales by Type (2017-2028)
10.2 South America Influenza Drugs and Vaccines Sales by Application (2017-2028)
10.3 South America Influenza Drugs and Vaccines Market Size by Country
10.3.1 South America Influenza Drugs and Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Influenza Drugs and Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Influenza Drugs and Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Influenza Drugs and Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Influenza Drugs and Vaccines Market Size by Country
11.3.1 Middle East & Africa Influenza Drugs and Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Influenza Drugs and Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Influenza Drugs and Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Influenza Drugs and Vaccines
12.3 Influenza Drugs and Vaccines Production Process
12.4 Influenza Drugs and Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Influenza Drugs and Vaccines Typical Distributors
13.3 Influenza Drugs and Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Figures, Tables and Charts Available in Global Influenza Drugs and Vaccines Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
List of TablesTable 1. Global Influenza Drugs and Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Influenza Drugs and Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol Myers Squibb Major Business
Table 5. Bristol Myers Squibb Influenza Drugs and Vaccines Product and Services
Table 6. Bristol Myers Squibb Influenza Drugs and Vaccines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Major Business
Table 9. AstraZeneca Influenza Drugs and Vaccines Product and Services
Table 10. AstraZeneca Influenza Drugs and Vaccines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 12. Eli Lilly Major Business
Table 13. Eli Lilly Influenza Drugs and Vaccines Product and Services
Table 14. Eli Lilly Influenza Drugs and Vaccines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Roche Basic Information, Manufacturing Base and Competitors
Table 16. Roche Major Business
Table 17. Roche Influenza Drugs and Vaccines Product and Services
Table 18. Roche Influenza Drugs and Vaccines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Major Business
Table 21. GlaxoSmithKline Influenza Drugs and Vaccines Product and Services
Table 22. GlaxoSmithKline Influenza Drugs and Vaccines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Influenza Drugs and Vaccines Product and Services
Table 26. Novartis Influenza Drugs and Vaccines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Pfizer Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer Major Business
Table 29. Pfizer Influenza Drugs and Vaccines Product and Services
Table 30. Pfizer Influenza Drugs and Vaccines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Pasteur Major Business
Table 33. Sanofi Pasteur Influenza Drugs and Vaccines Product and Services
Table 34. Sanofi Pasteur Influenza Drugs and Vaccines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Bayer Basic Information, Manufacturing Base and Competitors
Table 36. Bayer Major Business
Table 37. Bayer Influenza Drugs and Vaccines Product and Services
Table 38. Bayer Influenza Drugs and Vaccines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Celgene Basic Information, Manufacturing Base and Competitors
Table 40. Celgene Major Business
Table 41. Celgene Influenza Drugs and Vaccines Product and Services
Table 42. Celgene Influenza Drugs and Vaccines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Seqirus Basic Information, Manufacturing Base and Competitors
Table 44. Seqirus Major Business
Table 45. Seqirus Influenza Drugs and Vaccines Product and Services
Table 46. Seqirus Influenza Drugs and Vaccines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Protein Sciences Corporation Basic Information, Manufacturing Base and Competitors
Table 48. Protein Sciences Corporation Major Business
Table 49. Protein Sciences Corporation Influenza Drugs and Vaccines Product and Services
Table 50. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 52. Serum Institute of India Major Business
Table 53. Serum Institute of India Influenza Drugs and Vaccines Product and Services
Table 54. Serum Institute of India Influenza Drugs and Vaccines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Emergent Biosolutions Basic Information, Manufacturing Base and Competitors
Table 56. Emergent Biosolutions Major Business
Table 57. Emergent Biosolutions Influenza Drugs and Vaccines Product and Services
Table 58. Emergent Biosolutions Influenza Drugs and Vaccines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. BioCryst Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. BioCryst Pharmaceuticals Major Business
Table 61. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product and Services
Table 62. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Alvogen Basic Information, Manufacturing Base and Competitors
Table 64. Alvogen Major Business
Table 65. Alvogen Influenza Drugs and Vaccines Product and Services
Table 66. Alvogen Influenza Drugs and Vaccines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Global Influenza Drugs and Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 68. Global Influenza Drugs and Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 69. Market Position of Manufacturers in Influenza Drugs and Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 70. Global Influenza Drugs and Vaccines Production Capacity by Company, (MT): 2020 VS 2021
Table 71. Head Office and Influenza Drugs and Vaccines Production Site of Key Manufacturer
Table 72. Influenza Drugs and Vaccines New Entrant and Capacity Expansion Plans
Table 73. Influenza Drugs and Vaccines Mergers & Acquisitions in the Past Five Years
Table 74. Global Influenza Drugs and Vaccines Sales by Region (2017-2022) & (MT)
Table 75. Global Influenza Drugs and Vaccines Sales by Region (2023-2028) & (MT)
Table 76. Global Influenza Drugs and Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 77. Global Influenza Drugs and Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 78. Global Influenza Drugs and Vaccines Sales by Type (2017-2022) & (MT)
Table 79. Global Influenza Drugs and Vaccines Sales by Type (2023-2028) & (MT)
Table 80. Global Influenza Drugs and Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 81. Global Influenza Drugs and Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 82. Global Influenza Drugs and Vaccines Price by Type (2017-2022) & (USD/Kg)
Table 83. Global Influenza Drugs and Vaccines Price by Type (2023-2028) & (USD/Kg)
Table 84. Global Influenza Drugs and Vaccines Sales by Application (2017-2022) & (MT)
Table 85. Global Influenza Drugs and Vaccines Sales by Application (2023-2028) & (MT)
Table 86. Global Influenza Drugs and Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 87. Global Influenza Drugs and Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 88. Global Influenza Drugs and Vaccines Price by Application (2017-2022) & (USD/Kg)
Table 89. Global Influenza Drugs and Vaccines Price by Application (2023-2028) & (USD/Kg)
Table 90. North America Influenza Drugs and Vaccines Sales by Country (2017-2022) & (MT)
Table 91. North America Influenza Drugs and Vaccines Sales by Country (2023-2028) & (MT)
Table 92. North America Influenza Drugs and Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 93. North America Influenza Drugs and Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 94. North America Influenza Drugs and Vaccines Sales by Type (2017-2022) & (MT)
Table 95. North America Influenza Drugs and Vaccines Sales by Type (2023-2028) & (MT)
Table 96. North America Influenza Drugs and Vaccines Sales by Application (2017-2022) & (MT)
Table 97. North America Influenza Drugs and Vaccines Sales by Application (2023-2028) & (MT)
Table 98. Europe Influenza Drugs and Vaccines Sales by Country (2017-2022) & (MT)
Table 99. Europe Influenza Drugs and Vaccines Sales by Country (2023-2028) & (MT)
Table 100. Europe Influenza Drugs and Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 101. Europe Influenza Drugs and Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 102. Europe Influenza Drugs and Vaccines Sales by Type (2017-2022) & (MT)
Table 103. Europe Influenza Drugs and Vaccines Sales by Type (2023-2028) & (MT)
Table 104. Europe Influenza Drugs and Vaccines Sales by Application (2017-2022) & (MT)
Table 105. Europe Influenza Drugs and Vaccines Sales by Application (2023-2028) & (MT)
Table 106. Asia-Pacific Influenza Drugs and Vaccines Sales by Region (2017-2022) & (MT)
Table 107. Asia-Pacific Influenza Drugs and Vaccines Sales by Region (2023-2028) & (MT)
Table 108. Asia-Pacific Influenza Drugs and Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 109. Asia-Pacific Influenza Drugs and Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 110. Asia-Pacific Influenza Drugs and Vaccines Sales by Type (2017-2022) & (MT)
Table 111. Asia-Pacific Influenza Drugs and Vaccines Sales by Type (2023-2028) & (MT)
Table 112. Asia-Pacific Influenza Drugs and Vaccines Sales by Application (2017-2022) & (MT)
Table 113. Asia-Pacific Influenza Drugs and Vaccines Sales by Application (2023-2028) & (MT)
Table 114. South America Influenza Drugs and Vaccines Sales by Country (2017-2022) & (MT)
Table 115. South America Influenza Drugs and Vaccines Sales by Country (2023-2028) & (MT)
Table 116. South America Influenza Drugs and Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 117. South America Influenza Drugs and Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 118. South America Influenza Drugs and Vaccines Sales by Type (2017-2022) & (MT)
Table 119. South America Influenza Drugs and Vaccines Sales by Type (2023-2028) & (MT)
Table 120. South America Influenza Drugs and Vaccines Sales by Application (2017-2022) & (MT)
Table 121. South America Influenza Drugs and Vaccines Sales by Application (2023-2028) & (MT)
Table 122. Middle East & Africa Influenza Drugs and Vaccines Sales by Region (2017-2022) & (MT)
Table 123. Middle East & Africa Influenza Drugs and Vaccines Sales by Region (2023-2028) & (MT)
Table 124. Middle East & Africa Influenza Drugs and Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 125. Middle East & Africa Influenza Drugs and Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 126. Middle East & Africa Influenza Drugs and Vaccines Sales by Type (2017-2022) & (MT)
Table 127. Middle East & Africa Influenza Drugs and Vaccines Sales by Type (2023-2028) & (MT)
Table 128. Middle East & Africa Influenza Drugs and Vaccines Sales by Application (2017-2022) & (MT)
Table 129. Middle East & Africa Influenza Drugs and Vaccines Sales by Application (2023-2028) & (MT)
Table 130. Influenza Drugs and Vaccines Raw Material
Table 131. Key Manufacturers of Influenza Drugs and Vaccines Raw Materials
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Influenza Drugs and Vaccines Typical Distributors
Table 135. Influenza Drugs and Vaccines Typical Customers
List of Figures
Figure 1. Influenza Drugs and Vaccines Picture
Figure 2. Global Influenza Drugs and Vaccines Revenue Market Share by Type in 2021
Figure 3. Influenza Drugs
Figure 4. Influenza Vaccines
Figure 5. Global Influenza Drugs and Vaccines Revenue Market Share by Application in 2021
Figure 6. Hospital Pharmacy
Figure 7. Retail Pharmacy
Figure 8. Online Pharmacy
Figure 9. Global Influenza Drugs and Vaccines Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 10. Global Influenza Drugs and Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Influenza Drugs and Vaccines Sales (2017-2028) & (MT)
Figure 12. Global Influenza Drugs and Vaccines Price (2017-2028) & (USD/Kg)
Figure 13. Global Influenza Drugs and Vaccines Production Capacity (2017-2028) & (MT)
Figure 14. Global Influenza Drugs and Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Influenza Drugs and Vaccines Market Drivers
Figure 16. Influenza Drugs and Vaccines Market Restraints
Figure 17. Influenza Drugs and Vaccines Market Trends
Figure 18. Global Influenza Drugs and Vaccines Sales Market Share by Manufacturer in 2021
Figure 19. Global Influenza Drugs and Vaccines Revenue Market Share by Manufacturer in 2021
Figure 20. Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Influenza Drugs and Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Influenza Drugs and Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Influenza Drugs and Vaccines Sales Market Share by Region (2017-2028)
Figure 24. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2017-2028)
Figure 25. North America Influenza Drugs and Vaccines Revenue (2017-2028) & (USD Million)
Figure 26. Europe Influenza Drugs and Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Influenza Drugs and Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. South America Influenza Drugs and Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Influenza Drugs and Vaccines Revenue (2017-2028) & (USD Million)
Figure 30. Global Influenza Drugs and Vaccines Sales Market Share by Type (2017-2028)
Figure 31. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2017-2028)
Figure 32. Global Influenza Drugs and Vaccines Price by Type (2017-2028) & (USD/Kg)
Figure 33. Global Influenza Drugs and Vaccines Sales Market Share by Application (2017-2028)
Figure 34. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2017-2028)
Figure 35. Global Influenza Drugs and Vaccines Price by Application (2017-2028) & (USD/Kg)
Figure 36. North America Influenza Drugs and Vaccines Sales Market Share by Type (2017-2028)
Figure 37. North America Influenza Drugs and Vaccines Sales Market Share by Application (2017-2028)
Figure 38. North America Influenza Drugs and Vaccines Sales Market Share by Country (2017-2028)
Figure 39. North America Influenza Drugs and Vaccines Revenue Market Share by Country (2017-2028)
Figure 40. United States Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Influenza Drugs and Vaccines Sales Market Share by Type (2017-2028)
Figure 44. Europe Influenza Drugs and Vaccines Sales Market Share by Application (2017-2028)
Figure 45. Europe Influenza Drugs and Vaccines Sales Market Share by Country (2017-2028)
Figure 46. Europe Influenza Drugs and Vaccines Revenue Market Share by Country (2017-2028)
Figure 47. Germany Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Influenza Drugs and Vaccines Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Influenza Drugs and Vaccines Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Influenza Drugs and Vaccines Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Influenza Drugs and Vaccines Revenue Market Share by Region (2017-2028)
Figure 56. China Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Influenza Drugs and Vaccines Sales Market Share by Type (2017-2028)
Figure 63. South America Influenza Drugs and Vaccines Sales Market Share by Application (2017-2028)
Figure 64. South America Influenza Drugs and Vaccines Sales Market Share by Country (2017-2028)
Figure 65. South America Influenza Drugs and Vaccines Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Influenza Drugs and Vaccines Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Influenza Drugs and Vaccines Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Influenza Drugs and Vaccines Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Influenza Drugs and Vaccines Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Influenza Drugs and Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Influenza Drugs and Vaccines in 2021
Figure 77. Manufacturing Process Analysis of Influenza Drugs and Vaccines
Figure 78. Influenza Drugs and Vaccines Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Keyplayers in Global Influenza Drugs and Vaccines Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
Bristol Myers SquibbAstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
Request Sample
Request Discount
